Lipid-Based Nanoparticles for Drug Delivery in Cancer
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 3287
Special Issue Editors
Interests: drug delivery systems; solid lipid nanoparticles microemulsions; nanoemulsions; nanostructured lipid carriers; targeting
Interests: drug delivery systems; solid lipid nanoparticles microemulsions; nanoemulsions; nanostructured lipid carriers; targeting
Special Issue Information
Dear Colleagues,
We are planning to publish a Special Issue based on “Lipid-Based Nanoparticles for Drug Delivery in Cancer” in the journal Pharmaceutics.
Often, cancer chemotherapy encounters several obstacles such as severe side effects, low specificity and stability, and a high incidence of drug-resistant tumor cells. Recently, the attention of researchers has mainly been focused on overcoming multidrug resistance, considered the main cause of chemotherapy failure. The use of nanotechnology and, in particular, of lipid-based nanoparticles as a drug delivery system is promising for avoiding these problems in many tumor types.
Authors are kindly invited to submit original papers, communications, and reviews regarding the potential applications of lipid-based nanocarriers as drug delivery systems for cancer therapy to be published in this Special Issue of Pharmaceutics. We look forward to receiving your contributions.
Dr. Daniela Chirio
Dr. Elena Peira
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- lipid nanoparticles
- nanocarriers
- drug delivery systems
- cancer
- chemotherapy